{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:06:58Z","timestamp":1740128818594,"version":"3.37.3"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T00:00:00Z","timestamp":1588982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,17]]},"DOI":"10.1093\/cid\/ciaa509","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T19:14:10Z","timestamp":1588101250000},"page":"2730-2731","source":"Crossref","is-referenced-by-count":1,"title":["Hepatitis C Virus Cure Is the Start of the End for Patients With Advanced Fibrosis\/Cirrhosis"],"prefix":"10.1093","volume":"71","author":[{"given":"Aradhna","family":"Seth","sequence":"first","affiliation":[{"name":"Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth E","family":"Sherman","sequence":"additional","affiliation":[{"name":"Division of Digestive Diseases, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,9]]},"reference":[{"key":"2020121703251719800_CIT0001","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/hep.28923","article-title":"Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy","volume":"65","author":"Flemming","year":"2017","journal-title":"Hepatology"},{"key":"2020121703251719800_CIT0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.02.022","article-title":"Treatment of HCV reduces viral hepatitis-associated liver-related mortality in patients: an ERCHIVES study [manuscript published online ahead of print 5 March 2020]","author":"Butt","year":"2020","journal-title":"J Hepatol"},{"key":"2020121703251719800_CIT0003","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"key":"2020121703251719800_CIT0004","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/hep.29707","article-title":"The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: an ERCHIVES study","volume":"67","author":"Li","year":"2018","journal-title":"Hepatology"},{"key":"2020121703251719800_CIT0005","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"2020121703251719800_CIT0006","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/jvh.12578","article-title":"Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy","volume":"23","author":"Knop","year":"2016","journal-title":"J Viral Hepat"},{"key":"2020121703251719800_CIT0007","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/hep.20062","article-title":"The hepatic venous pressure gradient: anything worth doing should be done right","volume":"39","author":"Groszmann","year":"2004","journal-title":"Hepatology"},{"key":"2020121703251719800_CIT0008","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"2020121703251719800_CIT0009","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/hep.30314","article-title":"Prioritization of therapeutic targets and trial design in cirrhotic portal hypertension","volume":"69","author":"Abraldes","year":"2019","journal-title":"Hepatology"},{"key":"2020121703251719800_CIT0010","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/hep.30885","article-title":"Changes in hepatic venous pressure gradient predict hepatic decompensation in patients who achieved sustained virologic response to interferon-free therapy","volume":"71","author":"Mandorfer","year":"2020","journal-title":"Hepatology"},{"key":"2020121703251719800_CIT0011","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/jvh.12706","article-title":"Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension","volume":"24","author":"Afdhal","year":"2017","journal-title":"J Viral Hepat"},{"key":"2020121703251719800_CIT0012","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1053\/j.gastro.2017.07.016","article-title":"Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus\u2013associated cirrhosis","volume":"153","author":"Lens","year":"2017","journal-title":"Gastroenterology"},{"key":"2020121703251719800_CIT0013","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1111\/j.1572-0241.2007.01428.x","article-title":"Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV","volume":"102","author":"Schiano","year":"2007","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa509\/33712562\/ciaa509.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/10\/2730\/34933089\/ciaa509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/10\/2730\/34933089\/ciaa509.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T20:14:18Z","timestamp":1608322458000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/10\/2730\/5835187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,9]]},"references-count":13,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,5,9]]},"published-print":{"date-parts":[[2020,12,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa509","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published-other":{"date-parts":[[2020,11,15]]},"published":{"date-parts":[[2020,5,9]]}}}